ES8502989A1 - Un metodo de preparar compuestos de diaminopirimidina - Google Patents
Un metodo de preparar compuestos de diaminopirimidinaInfo
- Publication number
- ES8502989A1 ES8502989A1 ES525490A ES525490A ES8502989A1 ES 8502989 A1 ES8502989 A1 ES 8502989A1 ES 525490 A ES525490 A ES 525490A ES 525490 A ES525490 A ES 525490A ES 8502989 A1 ES8502989 A1 ES 8502989A1
- Authority
- ES
- Spain
- Prior art keywords
- diaminopyrimidines
- production
- pyrimidinediamine
- piperazinyl
- antibacterial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229940058936 antimalarials diaminopyrimidines Drugs 0.000 title 1
- MISVBCMQSJUHMH-UHFFFAOYSA-N pyrimidine-4,6-diamine Chemical class NC1=CC(N)=NC=N1 MISVBCMQSJUHMH-UHFFFAOYSA-N 0.000 title 1
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- -1 Substituted-phenyl Chemical class 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/50—Three nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41640482A | 1982-09-09 | 1982-09-09 | |
| US06/520,653 US4532240A (en) | 1982-09-09 | 1983-08-09 | Diaminopyrimidines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES525490A0 ES525490A0 (es) | 1985-02-01 |
| ES8502989A1 true ES8502989A1 (es) | 1985-02-01 |
Family
ID=27023342
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES525490A Expired ES8502989A1 (es) | 1982-09-09 | 1983-09-08 | Un metodo de preparar compuestos de diaminopirimidina |
| ES531004A Granted ES531004A0 (es) | 1982-09-09 | 1984-03-27 | Un metodo de preparar compuestos de diaminopirimidina |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES531004A Granted ES531004A0 (es) | 1982-09-09 | 1984-03-27 | Un metodo de preparar compuestos de diaminopirimidina |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US4532240A (OSRAM) |
| EP (1) | EP0103464B1 (OSRAM) |
| AU (2) | AU560971B2 (OSRAM) |
| CA (1) | CA1251447A (OSRAM) |
| DE (1) | DE3378469D1 (OSRAM) |
| DK (1) | DK158310C (OSRAM) |
| ES (2) | ES8502989A1 (OSRAM) |
| GR (1) | GR79058B (OSRAM) |
| IE (1) | IE56148B1 (OSRAM) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE35053E (en) * | 1985-09-12 | 1995-10-10 | The Upjohn Company | Amines useful in producing pharmaceutically active CNS compounds |
| US5099019A (en) * | 1985-09-12 | 1992-03-24 | Upjohn Company | Amines useful in producing pharmaceutically active CNS compounds |
| LU86695A1 (fr) * | 1986-12-01 | 1988-07-14 | Oreal | Nouveaux derives de piperazinyl-1 pyrimidine,leur preparation et leur application en therapeutique et cosmetique |
| HUT64323A (en) * | 1992-06-09 | 1993-12-28 | Richter Gedeon Vegyeszet | Process for production new piperazinyl-bis(alkyl-amino)-pyrimidine derivatives |
| ATE166347T1 (de) * | 1993-02-26 | 1998-06-15 | Max Delbrueck Centrum | Verfahren zur herstellung von c-nukleosiden und c-nukleosid-analoga, neue c-nukleoside und c- nukleosid-analoga, sowie ihre verwendung |
| DE4320570C2 (de) * | 1993-02-26 | 2002-07-11 | Max Delbrueck Centrum | Verfahren zur Herstellung von C-Nukleosiden und C-Nukleosid-Analoga, neue C-Nukleoside und C-Nukleosid-Analoga sowie deren Verwendung |
| GB9801392D0 (en) * | 1998-01-22 | 1998-03-18 | Smithkline Beecham Plc | Novel compounds |
| EP1057818A4 (en) | 1998-01-30 | 2003-01-29 | Meiji Seika Kaisha | PHENYLPIPERAZINE DERIVATIVES AS ANTAGONISTS OF INTEGRIN ALPHAvBETA3 |
| AU4690999A (en) * | 1998-08-13 | 2000-03-06 | Warner-Lambert Company | Diaminopyrimidines and combination therapies effective for treatment of p-glycoprotein positive cancers |
| US20040006042A1 (en) * | 1998-08-13 | 2004-01-08 | Berry David Allen | Diaminopyrimidines and combination therapies effective for treatment of P-glycoprotein positive cancers |
| EP1389189A2 (en) | 2001-05-22 | 2004-02-18 | Neurogen Corporation | Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
| GB0412072D0 (en) * | 2004-05-28 | 2004-06-30 | Syngenta Participations Ag | Chemical compounds |
| AU2017213824B9 (en) * | 2016-02-05 | 2021-11-25 | Vyera Pharmaceuticals, LLC | Compositions and methods for treating infections |
| US20200270233A1 (en) * | 2017-08-07 | 2020-08-27 | Vyera Pharmaceuticais LLC | Dhfr inhibitors, compositions, and methods related thereto |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US416404A (en) | 1889-12-03 | Automatic lath-feeder for paper-carriers | ||
| NL72956C (OSRAM) * | 1947-11-12 | |||
| US2748125A (en) * | 1954-04-26 | 1956-05-29 | American Cyanamid Co | 1-substituted-4-sulfamylpiperazine and method of preparing the same |
| AT340933B (de) * | 1973-08-20 | 1978-01-10 | Thomae Gmbh Dr K | Verfahren zur herstellung neuer pyrimidinderivate und ihrer saureadditionssalze |
| US4166852A (en) * | 1974-08-09 | 1979-09-04 | Produits Chimiques Ugine Kuhlmann | Piperazino-pyrimidines and their use as spasmolytic agents |
| US4287338A (en) * | 1980-03-10 | 1981-09-01 | The Upjohn Company | Sulfooxy-pyrimidinium, -pyridinium, and -triazinium hydroxide inner salts |
| US4351832A (en) * | 1980-04-18 | 1982-09-28 | American Home Products Corporation | 2-(Piperazinyl)-4-pyrimidinamines |
-
1983
- 1983-08-09 US US06/520,653 patent/US4532240A/en not_active Expired - Lifetime
- 1983-08-16 IE IE1920/83A patent/IE56148B1/en not_active IP Right Cessation
- 1983-09-05 AU AU18699/83A patent/AU560971B2/en not_active Ceased
- 1983-09-07 GR GR72395A patent/GR79058B/el unknown
- 1983-09-08 DE DE8383305229T patent/DE3378469D1/de not_active Expired
- 1983-09-08 ES ES525490A patent/ES8502989A1/es not_active Expired
- 1983-09-08 EP EP83305229A patent/EP0103464B1/en not_active Expired
- 1983-09-08 CA CA000436240A patent/CA1251447A/en not_active Expired
- 1983-09-08 DK DK407383A patent/DK158310C/da not_active IP Right Cessation
-
1984
- 1984-03-27 ES ES531004A patent/ES531004A0/es active Granted
-
1987
- 1987-02-13 AU AU68787/87A patent/AU568997B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| DK158310C (da) | 1990-10-15 |
| CA1251447A (en) | 1989-03-21 |
| DK158310B (da) | 1990-04-30 |
| IE831920L (en) | 1984-03-09 |
| AU560971B2 (en) | 1987-04-30 |
| EP0103464A3 (en) | 1985-07-03 |
| DK407383A (da) | 1984-03-10 |
| ES8504775A1 (es) | 1985-05-01 |
| GR79058B (OSRAM) | 1984-10-02 |
| IE56148B1 (en) | 1991-05-08 |
| ES525490A0 (es) | 1985-02-01 |
| ES531004A0 (es) | 1985-05-01 |
| DK407383D0 (da) | 1983-09-08 |
| AU1869983A (en) | 1984-03-15 |
| EP0103464B1 (en) | 1988-11-17 |
| AU568997B2 (en) | 1988-01-14 |
| DE3378469D1 (en) | 1988-12-22 |
| US4532240A (en) | 1985-07-30 |
| AU6878787A (en) | 1987-05-14 |
| EP0103464A2 (en) | 1984-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG103945A (en) | Derivatives of 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a | |
| BG103947A (en) | Derivatives of 9-oxymerythromycin | |
| BG103292A (en) | 6-0-substituted ketolides possessing antibacterial effect | |
| ES8502687A1 (es) | Procedimiento para preparar derivados de 4-oxo-1,4-dihidroquinoleina. | |
| FI952607A0 (fi) | Farmakologisesti aktiiviset pyridiinijohdannaiset ja menetelmät niiden valmistamiseksi | |
| ES8504775A1 (es) | Un metodo de preparar compuestos de diaminopirimidina | |
| YU41500A (sh) | Novi makrolidi | |
| MY124122A (en) | Heterocyclic derivatives | |
| BG105543A (en) | Novel macrolide antibiotics | |
| YU62999A (sh) | C-4"-supstituisani derivati makrolida | |
| EA200100623A1 (ru) | Кетолидные антибиотики | |
| AP2001002142A0 (en) | 13-membered azalides and their use as antibiotic agents. | |
| PA8486401A1 (es) | Antibioticos cetolidos carbamato y carbazato | |
| HUT73433A (en) | Process for preparing pharmaceutical compositions containing riluzole for treating aids-related neural disorders | |
| MY131300A (en) | Antibacterial agents | |
| NZ510153A (en) | Tan-1057 derivatives with reduced toxicity and their use in medicaments for treating bacterial infections in humans and mammals | |
| MX9708611A (es) | Compuestos de dialquiltiacumicina. | |
| ES8301244A1 (es) | Procedimiento para la obtencion de derivados de sisomicina. | |
| ES482698A1 (es) | Procedimiento para la obtencion de pseudotrisaceridos. | |
| ES8102147A1 (es) | Procedimiento para la obtencion de derivados de sisomicina | |
| BG105008A (en) | Hygromycin a derivatives | |
| ES8403968A1 (es) | Procedimiento para obtener compuestos antibioticos que contienen fosforo. | |
| GEP20022840B (en) | Form VI 5,6-Dichloro-2-(Isopropylamino)-1-(Beta-L-Ribofuranosyl-1H-Benzimidazole), Method for Their Production, Composition for Treating Virus Infections and Methods for Treatment | |
| TR200003249T2 (tr) | 2''-Deoksi higromisin türevleri | |
| ES8601200A1 (es) | Un procedimiento para preparar compuestos de 3-(2-haloetil)-4-oxopirazolo-(5, 1-d)-1, 2, 3, 5-tetrazin-8-carboxamida |